Insider-Trading
Aktuelle Insider-Transaktionen (SEC Form 4) — Käufe und Verkäufe von Vorständen, Direktoren und Großaktionären.
| Ticker | Insider | Funktion | Datum | Transaktion | Kurs ($) | Stück | Wert ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| BLLN | Tsao David | Chief Technology Officer | 05.10.2026 | Verkauf | 110,09 | 100 | 11.009 | Form 4 |
| BLLN | Tsao David | Chief Technology Officer | 05.10.2026 | Verkauf | 109,14 | 1.829 | 199.625 | Form 4 |
| BLLN | Tsao David | Chief Technology Officer | 05.10.2026 | Verkauf | 108,53 | 4.916 | 533.554 | Form 4 |
| BLLN | Tsao David | Chief Technology Officer | 05.10.2026 | Verkauf | 107,47 | 2.200 | 236.435 | Form 4 |
| BLLN | Tsao David | Chief Technology Officer | 05.10.2026 | Verkauf | 106,10 | 400 | 42.442 | Form 4 |
| BLLN | Tsao David | Chief Technology Officer | 05.10.2026 | Verkauf | 105,56 | 555 | 58.585 | Form 4 |
| BLLN | Tsao David | Chief Technology Officer | 05.10.2026 | Verkauf | 110,08 | 20 | 2.202 | Form 4 |
| BLLN | Tsao David | Chief Technology Officer | 05.10.2026 | Verkauf | 109,00 | 2.921 | 318.398 | Form 4 |
| BLLN | Tsao David | Chief Technology Officer | 05.10.2026 | Verkauf | 108,39 | 4.284 | 464.356 | Form 4 |
| BLLN | Tsao David | Chief Technology Officer | 05.10.2026 | Verkauf | 107,20 | 1.909 | 204.635 | Form 4 |
| BLLN | Tsao David | Chief Technology Officer | 05.10.2026 | Verkauf | 105,90 | 866 | 91.710 | Form 4 |
| BLLN | Tsao David | Chief Technology Officer | 05.10.2026 | Optionsausübung | 2,80 | 10.000 | 28.000 | Form 4 |
| BLLN | ten Bosch John Roderick | SVP of Laboratory Operations | 05.10.2026 | Verkauf | 105,15 | 1.417 | 148.998 | Form 4 |
| BLMN | Spanos Mike | CEO | 01.10.2026 | Steuer-Abgabe | 8,38 | 23.643 | 198.128 | Form 4 |
| BLMN | Spanos Mike | CEO | 01.10.2026 | Optionsausübung | — | 60.082 | — | Form 4 |
| BLTE | Scholl Hendrik Peter | Chief Medical Officer | 01.10.2026 | Verkauf | 170,02 | 2 | 340 | Form 4 |
| BLTE | Scholl Hendrik Peter | Chief Medical Officer | 01.10.2026 | Verkauf | 169,36 | 14 | 2.371 | Form 4 |
| BLTE | Scholl Hendrik Peter | Chief Medical Officer | 01.10.2026 | Verkauf | 168,21 | 12 | 2.019 | Form 4 |
| BLTE | Scholl Hendrik Peter | Chief Medical Officer | 01.10.2026 | Verkauf | 167,59 | 78 | 13.072 | Form 4 |
| BLTE | Scholl Hendrik Peter | Chief Medical Officer | 01.10.2026 | Verkauf | 166,44 | 50 | 8.322 | Form 4 |
| BLTE | Scholl Hendrik Peter | Chief Medical Officer | 01.10.2026 | Verkauf | 165,49 | 120 | 19.859 | Form 4 |
| BLTE | Scholl Hendrik Peter | Chief Medical Officer | 01.10.2026 | Verkauf | 164,64 | 24 | 3.951 | Form 4 |
| BLTE | Scholl Hendrik Peter | Chief Medical Officer | 01.10.2026 | Verkauf | 163,63 | 200 | 32.725 | Form 4 |
| BLK | Freda Fabrizio | Director | 30.09.2026 | Zuteilung | — | 18 | — | Form 4 |
| BLK | Vestberg Hans Erik | Director | 30.09.2026 | Zuteilung | — | 33 | — | Form 4 |
| BLK | Robbins Charles | Director | 30.09.2026 | Zuteilung | — | 27 | — | Form 4 |
| BLK | Peck Kristin C | Director | 30.09.2026 | Zuteilung | — | 30 | — | Form 4 |
| BLK | Nixon Gordon M. | Director | 30.09.2026 | Zuteilung | — | 34 | — | Form 4 |
| BLK | Nasser Amin H. | Director | 30.09.2026 | Zuteilung | — | 27 | — | Form 4 |
| BLK | Murphy Kathleen | Director | 30.09.2026 | Zuteilung | — | 36 | — | Form 4 |
| BLK | Lemkau Gregg | Director | 30.09.2026 | Zuteilung | — | 27 | — | Form 4 |
| BLK | Johnson Margaret L | Director | 30.09.2026 | Zuteilung | — | 33 | — | Form 4 |
| BLK | Ford William E | Director | 30.09.2026 | Zuteilung | — | 34 | — | Form 4 |
| BLK | Daley Pamela | Director | 30.09.2026 | Zuteilung | — | 27 | — | Form 4 |
| BLND | Ghamsari Nima | HEAD OF BLEND | 28.09.2026 | Verkauf | 1,10 | 22.523 | 24.820 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 28.09.2026 | Verkauf | 120,64 | 2.666 | 321.626 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 28.09.2026 | Verkauf | 120,64 | 8.333 | 1.005.293 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 28.09.2026 | Optionsausübung | 2,80 | 8.333 | 23.332 | Form 4 |
| BLTE | Chen Wan-Shan | Director | 24.09.2026 | Optionsausübung | 0,4386 | 13.796 | 6.051 | Form 4 |
| BLSH | Bliss Andrew | Director | 24.09.2026 | Verkauf | 40,10 | 100 | 4.010 | Form 4 |
| BLLN | Tsao David | Chief Technology Officer | 24.09.2026 | Verkauf | 125,00 | 3.333 | 416.625 | Form 4 |
| BLLN | Tsao David | Chief Technology Officer | 24.09.2026 | Optionsausübung | 2,80 | 3.333 | 9.332 | Form 4 |
| BLLN | ten Bosch John Roderick | SVP of Laboratory Operations | 24.09.2026 | Verkauf | 120,00 | 1.416 | 169.920 | Form 4 |
| BLSH | Bliss Andrew | Director | 23.09.2026 | Verkauf | 40,22 | 59.976 | 2.412.031 | Form 4 |
| BLSH | Bliss Andrew | Director | 22.09.2026 | Verkauf | 40,79 | 108.200 | 4.413.056 | Form 4 |
| BLSH | Bliss Andrew | Director | 21.09.2026 | Verkauf | 40,20 | 76.953 | 3.093.888 | Form 4 |
| BLND | Ghamsari Nima | HEAD OF BLEND | 21.09.2026 | Verkauf | 1,19 | 21.009 | 25.022 | Form 4 |
| BLLN | ten Bosch John Roderick | SVP of Laboratory Operations | 21.09.2026 | Verkauf | 106,61 | 1.416 | 150.960 | Form 4 |
| BLFS | Berard Todd | Chief Marketing Officer | 18.09.2026 | Steuer-Abgabe | 36,69 | 470 | 17.244 | Form 4 |
| BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | 18.09.2026 | Steuer-Abgabe | 36,69 | 564 | 20.693 | Form 4 |
| BLFS | Werner Sean | Chief Technology Officer | 18.09.2026 | Steuer-Abgabe | 36,69 | 421 | 15.446 | Form 4 |
| BLFS | De Greef Roderick | President and CEO | 18.09.2026 | Steuer-Abgabe | 36,69 | 2.775 | 101.815 | Form 4 |
| BLFS | Wichterman Troy | Chief Financial Officer | 18.09.2026 | Steuer-Abgabe | 36,69 | 937 | 34.379 | Form 4 |
| BLLN | Lynch Thomas P. | See Remarks | 17.09.2026 | Verkauf | 110,29 | 5.840 | 644.112 | Form 4 |
| BLLN | Lynch Thomas P. | See Remarks | 17.09.2026 | Verkauf | 110,31 | 2.920 | 322.100 | Form 4 |
| BLLN | Lynch Thomas P. | See Remarks | 17.09.2026 | Verkauf | 110,30 | 6.968 | 768.561 | Form 4 |
| BLLN | Lynch Thomas P. | See Remarks | 17.09.2026 | Verkauf | 110,36 | 19.384 | 2.139.193 | Form 4 |
| BLLN | Lynch Thomas P. | See Remarks | 17.09.2026 | Optionsausübung | 30,78 | 5.840 | 179.755 | Form 4 |
| BLLN | Lynch Thomas P. | See Remarks | 17.09.2026 | Optionsausübung | 17,12 | 2.920 | 49.990 | Form 4 |
| BLLN | Lynch Thomas P. | See Remarks | 17.09.2026 | Optionsausübung | 11,55 | 6.968 | 80.480 | Form 4 |
Kompakter Markt-Überblick — keine Anlageberatung. Quelle: Fundamentaldaten & SEC-Berichte (Geschäfts- und Quartalsberichte, 10-K/10-Q).